🔎 Trials Near Me

Akèy › Makroglobulinemi Waldenstrom › Colorado › Denver

Etid klinik pou Makroglobulinemi Waldenstrom nan Denver, CO

7 etid pou Makroglobulinemi Waldenstrom ap chèche patisipan nan sit nan ak bò kote Denver (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Ap rekriteFaz 2
  • Colorado Blood Cancer Institute ( Site 2726), Denver
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04728893

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

Ap rekriteFaz 2
  • Colorado Blood Cancer Institute (CBCI), Denver
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06561347

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT05131022

SynKIR-310 for Relapsed/Refractory B-NHL

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06544265

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Ap rekriteFaz 1
  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT04830137

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Ap rekriteFaz 1
  • Colorado Blood Cancer Institute, Denver
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05780034

Etid Makroglobulinemi Waldenstrom nan lòt vil

Lòt etid nan Denver

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.